Use of pegylated interferon alpha in preparation of a Medicine for Therapy against HIV

摘要

Use of interferon alpha,Alone and in combination with a Drug Therapy against hiv-1 and Ribavirin for the preparation of a Medicament for the treatment of patients who have not undergone treatments and patientsAdults and Children infected by HIV - 1 that have undergone treatments as well as patients coinfected with hiv-1 and HCV.Comprising a therapeutically effective amount of pegylated interferon alpha, e.g. interferon alfa-2a or alfa-2b pegylated, as monotherapy or, preferably,In combination with a therapeutically effective amount of at least one between ribavirin, il-2Il - 12 and pentafusida alone or in combination with a therapeutically effective amount of a Drug Therapy against hiv-1, e.g. HAART.